Mattson Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-652
Closed -$39.8K 179
2025
Q1
$39.8K Sell
652
-100
-13% -$5.83K 0.01% 189
2024
Q4
$38.9K Buy
752
+730
+3,318% +$40.8K 0.01% 186
2024
Q3
$914 Hold
22
﹤0.01% 251
2024
Q2
$914 Buy
+22
New +$984 ﹤0.01% 251

Other funds holding BMY

Mattson Financial Services's BMY Position: Q2 2025 in Review

Mattson Financial Services sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 652 shares — an estimated $39.8K sold.

Mattson Financial Services first reported a position in BMY in Q2 2024 and held it in 4 quarters. The position peaked at $39.8K in Q1 2025. 2,298 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Mattson Financial Services reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Mattson Financial Services sold 652 Bristol-Myers Squibb shares in Q2 2025, an estimated $39.8K.
  • Mattson Financial Services first reported a position in Bristol-Myers Squibb in Q2 2024 and held it in 4 quarters.
  • Mattson Financial Services's Bristol-Myers Squibb position peaked at $39.8K in Q1 2025.
  • 2,298 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Mattson Financial Services's 13F filing for Q2 2025, filed 29 Jul 2025.